137 related articles for article (PubMed ID: 2529828)
1. [Combined GnRH analogs/hMG/hCG treatment].
Braendle W
Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
[TBL] [Abstract][Full Text] [Related]
3. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
[TBL] [Abstract][Full Text] [Related]
4. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
[TBL] [Abstract][Full Text] [Related]
5. [Combined GnRH agonist/hMG therapy and ovarian overstimulation syndrome].
Lindner C; Braendle W; Lichtenberg V; Bettendorf G
Arch Gynecol Obstet; 1989; 245(1-4):860-1. PubMed ID: 2529827
[No Abstract] [Full Text] [Related]
6. Ovulation induction for in-vitro-fertilization and embryo transfer applying decapeptyl (DTRP-6 LH/RH) in combination with HMG or FSH.
Mettler L; Argiriou C; Abd-el Maeboud K; Steinmüller H; Semm K
Exp Clin Endocrinol; 1988 Mar; 92(3):245-51. PubMed ID: 2978123
[TBL] [Abstract][Full Text] [Related]
7. [Effect of low-dose corticoid administration (prednisolone 7.5 mg) on the quality of gonadotropin-induced cycle stimulation].
Würfel W; von Hertwig I; Steck T; Albert P
Arch Gynecol Obstet; 1989; 245(1-4):854-8. PubMed ID: 2529826
[No Abstract] [Full Text] [Related]
8. The impact of HCG in IVF Treatment: Does it depend on age or on protocol?
Theofanakis C; Athanasiou V; Liokari E; Stavrou S; Sakellariou M; Athanassiou AI; Athanassiou A; Drakakis P; Loutradis D
J Gynecol Obstet Hum Reprod; 2019 May; 48(5):341-345. PubMed ID: 30794953
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
Aboulghar MA; Mansour RT; Serour GI
Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
[TBL] [Abstract][Full Text] [Related]
10. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
Jiang S; Kuang Y
Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
[TBL] [Abstract][Full Text] [Related]
11. [GnRH agonist/hMG stimulation in gamete intrafallopian transfer (GIFT)].
Lindner C; Braendle W; Lichtenberg V; Bispink L; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():91-5. PubMed ID: 2522903
[TBL] [Abstract][Full Text] [Related]
12. [Increased incidence of ovarian hyperstimulation syndrome following combined GnRH agonist/hMG therapy].
Lindner C; Braendle W; Köhler S; Bettendorf G
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):337-44. PubMed ID: 2525500
[TBL] [Abstract][Full Text] [Related]
13. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
[TBL] [Abstract][Full Text] [Related]
14. The value of GnRH analogue therapy in IVF in women with unexplained infertility.
Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA
Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570
[TBL] [Abstract][Full Text] [Related]
15. In vitro fertilisation. A review of drug therapy and clinical management.
Jennings JC; Moreland K; Peterson CM
Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
[TBL] [Abstract][Full Text] [Related]
16. The use of long-acting gonadotropin-releasing hormone agonist (GnRH-a; decapeptyl) and gonadotropins versus short-acting GnRH-a (buserelin) and gonadotropins before and during ovarian stimulation for in vitro fertilization (IVF).
Gonen Y; Dirnfeld M; Goldman S; Koifman M; Abramovici H
J In Vitro Fert Embryo Transf; 1991 Oct; 8(5):254-9. PubMed ID: 1836810
[TBL] [Abstract][Full Text] [Related]
17. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
[TBL] [Abstract][Full Text] [Related]
18. Ovarian stimulation with buserelin/HMG/HCG: prospective randomized study of short versus long protocol.
Tarlatzis BC; Pados G; Bontis J; Lagos S; Grimbizis G; Spanos E; Mantalenakis S
Hum Reprod; 1993 Jun; 8(6):807-12. PubMed ID: 8345067
[TBL] [Abstract][Full Text] [Related]
19. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
20. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
